Pavion Blue Capital’s AbbVie ABBV Stock Holding History

Pavion Blue Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.83M	Hold	8,426	–	–	0.8%	36
2025 Q4	$1.93M	Hold	8,426	–	–	0.8%	35
2025 Q3	$1.95M	Hold	8,426	–	–	0.83%	35
2025 Q2	$1.56M	Hold	8,426	–	–	0.69%	35
2025 Q1	$1.77M	Hold	8,426	–	–	0.84%	35
2024 Q4	$1.5M	Sell	8,426 -250	-3%	-$46K	0.7%	39
2024 Q3	$1.71M	Sell	8,676 -8	-0.1%	-$1.49K	0.8%	37
2024 Q2	$1.49M	Hold	8,684	–	–	0.73%	38
2024 Q1	$1.58M	Hold	8,684	–	–	0.78%	40
2023 Q4	$1.35M	Hold	8,684	–	–	0.74%	41
2023 Q3	$1.16M	Hold	8,684	–	–	0.71%	41
2023 Q2	$1.17M	Buy	8,684 +220	+3%	+$32.3K	0.68%	41
2023 Q1	$1.35M	Hold	8,464	–	–	0.83%	37
2022 Q4	$1.37M	Buy	8,464 +300	+4%	+$46K	0.87%	35
2022 Q3	$1.1M	Buy	8,164 +100	+1%	+$14.3K	0.79%	37
2022 Q2	$1.24M	Buy	8,064 +15	+0.2%	+$2.29K	0.83%	38
2022 Q1	$1.3M	Buy	8,049 +300	+4%	+$43.6K	0.76%	36
2021 Q4	$1.05M	Sell	7,749 -259	-3%	-$30.6K	0.61%	40
2021 Q3	$864K	Hold	8,008	–	–	0.54%	46
2021 Q2	$902K	Sell	8,008 -500	-6%	-$56.3K	0.54%	49
2021 Q1	$921K	Sell	8,508 -43	-0.5%	-$4.6K	0.61%	45
2020 Q4	$916K	Hold	8,551	–	–	0.63%	42
2020 Q3	$749K	Hold	8,551	–	–	0.58%	44
2020 Q2	$840K	Buy	8,551 +80	+0.9%	+$7.04K	0.73%	37
2020 Q1	$645K	Buy	8,471 +3,588	+73%	+$306K	0.67%	39
2019 Q4	$432K	Buy	+4,883	New	+$405K	0.43%	38

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pavion Blue Capital's ABBV Position: Q1 2026 in Review

Pavion Blue Capital held its AbbVie (ABBV) position steady in Q1 2026 at 8,426 shares worth $1.83M. The position accounts for 0.8% of the portfolio, ranked #36.

Pavion Blue Capital first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.95M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Pavion Blue Capital held 8,426 shares of AbbVie worth $1.83M as of Q1 2026.
Pavion Blue Capital left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.8% of Pavion Blue Capital's portfolio in Q1 2026, its #36 holding.
Pavion Blue Capital first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
Pavion Blue Capital's AbbVie position peaked at $1.95M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.